Skip to content
Trial Eligibility
Menu

Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD

NCT07219810

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The objective of this project is to examine the differential therapeutic effect of intermittent theta burst stimulation (iTBS; a type of repetitive transcranial magnetic stimulation) to the left DLPFC versus right PreSMA in modulating working memory (WM) versus inhibitory control (IC) deficits. Fifty adolescents (12-18 years old) with parent-reported WM and IC deficits and diagnosed ADHD will be randomized to DLPFC or PreSMA targeted 3x-daily iTBS for a total of ten days (30 total sessions).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • ADHD

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
12 to 18 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Bradley Hospital
Last updated on ClinicalTrials.gov
October 22, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Rhode Island · 1

  • E. P. Bradley Hospital · East Providence, RI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.